Delivery Order SPE2DB20D7059-SPE2DB24FQCS4

Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,010,710 units of the pharmaceutical drug Venlafaxine HCL ER 75 mg capsules. The $1,864.74 contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA through December 31, 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Venlafaxine HCL ER 150 mg capsules, with a potential value of $1,095.12. The contract is a firm fixed price award, with a completion date of January 22, 2024. No set-aside designation was used. As a prime contractor, Amerisourcebergen Drug Corp has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,416.69, is for the delivery of Venlafaxine HCL ER 37.5 mg capsules. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through November 2023. There is no set-aside designation for this award. AmerisourceBergen holds a separate IDC with the...
This is a $56,290.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 1,000 units of the prescription medication Venlafaxine HCL ER 75 mg capsules. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,162.00 firm fixed-price contract is for the supply of 500 units of Venlafaxine HCL ER 75 MG capsules. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense...
This is a federal contract award worth $1,347.04 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4562766239 - Venlafaxine HCL ER 150 mg capsules in quantities of 90s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of November 9, 2023. This is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price (FFP) delivery order for the supply of 4,562,943,814 units of Venlafaxine 150mg tablets. The total ceiling value of the award is $7,296.42 and the ultimate completion date is December 28, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $84,900 to Amerisourcebergen Drug Corporation for the supply of 4561412098 venlafaxine hydrochloride extended release 150 mg capsules. Under the terms of the order, Amerisourcebergen will deliver 90 count bottles of the medication to a location in Conshohocken, Pennsylvania by July 6, 2023. The funding agency, DLA, utilizes contracts such as this to procure pharmaceuticals in support of the medical readiness of...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of 4,564,840,549 units of the prescription medication Venlafaxine HCL ER 75 mg capsules. The $15,994.51 firm-fixed price contract has a completion date of June 10, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the prescription medication Venlafaxine HCL ER 150 mg capsules, with a ceiling value of $2,140.72 and a performance period ending on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQCS4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,149.48 contract is for the delivery of 4,564,113,042 units of Venlafaxine HCl ER 150 mg capsules. The award has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 6/28/24, 9:45 AM